Skip to main content
INVENTURUS KNOWLEDGE SOLUTIONS LIMITED logo

INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Investor Relations & Filings

Ticker · IKS ISIN · INE115Q01022 LEI · 3358007O1GXF6BHBQX79 BSE.NS Administrative and support service activities
Open in API
Filings indexed 189 across all filing types
Latest filing 2025-07-01 Capital/Financing Update
Country IN India
Listing BSE.NS IKS

About INVENTURUS KNOWLEDGE SOLUTIONS LIMITED

https://ikshealth.com/

Inventurus Knowledge Solutions Limited, operating as IKS Health, provides administrative and clinical support solutions for healthcare organizations. The company offers a suite of services designed to manage the business functions of medical practices, including revenue cycle management, clinical documentation, and practice optimization. Key products include virtual scribing services, medical coding, and billing solutions that streamline provider workflows. The company also provides value-based care support and population health management tools to improve clinical outcomes and financial sustainability. By leveraging a combination of technology and domain expertise, the platform addresses administrative burdens, allowing clinicians to focus on patient care while enhancing operational efficiency and data accuracy across the care continuum.

Recent filings

Filing Released Lang Actions
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a strategic partnership and investment by IKS Health in Western Washington Medical Group. It is addressed to stock exchanges for dissemination, indicating it is a public announcement. The content focuses on business development and strategic investment rather than financial results, regulatory filings, or detailed financial data. There is no indication of financial statements, audit information, or management discussion of financial results. The document is not a report but an announcement of a corporate event. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to a strategic investment and partnership expansion involving capital deployment.
2025-07-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a notification addressed to stock exchanges (BSE and NSE) about an upcoming conference call regarding an investment by a subsidiary of the company. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), which pertains to disclosure of material events. The document includes details such as date, time, dial-in numbers, and webcast links for the conference call. There is no financial data or report content, only an announcement of the call. Therefore, this is a Call Transcript announcement or invitation, not the transcript itself. Given the options, the best fit is 'Call Transcript (CT)' as it relates to a conference call event. Confidence is high due to clear mention of conference call details and regulatory disclosure context.
2025-06-30 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding an investment by a subsidiary of the company in another entity. It details the approval by the Board of Directors for the investment, the nature of the investment, percentage of equity acquired, and background information about the target company. The document references Regulation 30 of SEBI Listing Regulations, which pertains to disclosure of material events or information by listed entities. The content focuses on the announcement of a strategic investment/acquisition and provides detailed information about the transaction but does not contain financial statements or comprehensive financial analysis. This fits the category of Capital/Financing Update (CAP), as it is an update on a significant investment and capital structure change by the company.
2025-06-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window for designated persons due to the upcoming announcement of the company's unaudited financial results for the quarter ended June 30, 2025. It references the SEBI (Prohibition of Insider Trading) Regulations and the timing of the trading window closure and reopening relative to the financial results announcement. The document does not contain any financial data or the results themselves, but is an announcement related to trading restrictions ahead of a financial report release. The document length is short (1456 characters), and it serves as a notification rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-06-27 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2025-06-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of an Analyst/Institutional Investor Meet. It references regulatory compliance under SEBI Listing Obligations but does not contain any financial data, results, or detailed presentations. It is essentially an announcement of an upcoming event rather than a report or transcript of the event. The document length is only 1470 characters, which is quite short and fits the pattern of a Regulatory Filing (RNS) rather than a full Investor Presentation (IP) or Call Transcript (CT). Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-06-09 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.